Recombinant Biotechnology and Immunotherapy Centre

Project objectives

The project focuses upon the development of recombinant high-affinity ligands, recombinant proteins and genetic DNA/RNA vaccines with corpuscular carriers and molecular adjuvants, a new biotechnological trend in the development of recombinant vaccines, highly selective immunotherapeutics, diagnostics, and theranostics. The success of proposed multidisciplinary research will be based on the collaboration of four renowned teams with a high quality of staffing and infrastructure. These teams have been engaged in a long-standing cooperation, as documented by shared projects, publications, and patents.


OP – EU Operational Programme

77,301 thou. CZK


Palacký University Olomouc/ Faculty of Medicine and Dentistry

Veterinary Research Institute

Institute of Biotechnology of the Czech Academy of Sciences

University of Chemistry and Technology Prague

Project researcher